Huarong Chemical (301256) 2025 Annual Report Brief Analysis: Revenue Growth Without Profit Increase, Accounts Receivable Rising

According to publicly available data compiled by Securities Star, Huaron Chemical (301256) recently released its 2025 annual report. As of the end of this reporting period, the company’s total operating revenue was 1.687 billion yuan, up 39.8% year-over-year, while net profit attributable to shareholders was 71.79 million yuan, down 28.57% year-over-year. Quarterly data shows that in the fourth quarter, total operating revenue was 423 million yuan, an increase of 10.32% year-over-year, and net profit attributable to shareholders was 18.68 million yuan, a decrease of 48.82% year-over-year. During this period, Huaron Chemical’s accounts receivable increased, with a year-over-year growth rate of 124.07%.

The financial data released in this report shows average performance. The gross profit margin was 9.21%, down 41.82% year-over-year; net profit margin was 4.26%, down 48.9% year-over-year. Total selling, administrative, and financial expenses amounted to 54.79 million yuan, accounting for 3.25% of revenue, a decrease of 47.14%. Net asset value per share was 3.6 yuan, down 0.23 yuan; operating cash flow per share was 0.05 yuan, an increase of 216.14%; earnings per share were 0.15 yuan, down 28.57%.

The reasons for significant changes in key financial items are explained as follows:

1. Financial expenses decreased by 36.91%, mainly due to reduced interest on short-term borrowings.
2. Net cash flow from operating activities increased by 216.14%, driven by expansion in supply chain business, increased sales scale, and higher cash received from sales.
3. Net cash flow from investing activities decreased by 39.60%, mainly because of a decline in net recovery of structured deposits.

Securities Star’s valuation analysis tools indicate:

• Business Evaluation: The company’s ROIC last year was 3.57%, indicating weak capital returns in recent years. The company’s performance is cyclical. Last year’s net profit margin was 4.26%, suggesting that after accounting for all costs, the company’s products or services have low added value. Historical annual report data shows that since the company’s listing, the median ROIC has been 9.19%, indicating relatively good investment returns. The worst year was 2017, with an ROIC of -2.53%, reflecting poor investment returns. Overall, the company’s historical financial reports are relatively average (note: the company has been listed for less than 10 years; the longer the listing, the more meaningful the financial averages).

• Solvency: The company’s cash assets are very healthy.

• Business Breakdown: Over the past three years (2023/2024/2025), net return on operating assets was 30.8%, 19.1%, and 13.5%, respectively. Net operating profits were 139 million, 100 million, and 71.79 million yuan, respectively, with net operating assets of 450 million, 526 million, and 531 million yuan.

  Over the past three years, the company’s working capital to revenue ratio was 0.16, 0.28, and 0.18, respectively. Working capital (funds invested by the company in its operations) was 172 million, 343 million, and 303 million yuan, while revenue was 1.059 billion, 1.206 billion, and 1.687 billion yuan.

Financial health check tools suggest:

1. Pay attention to the company’s cash flow status (average operating cash flow over the past three years divided by current liabilities is only 2.13%).
2. Monitor the company’s accounts receivable situation (accounts receivable to profit ratio has reached 242.92%).

The above content is compiled by Securities Star based on publicly available information, generated by AI algorithms (Wangxin Algorithm Record 310104345710301240019), and does not constitute investment advice.